Related Experiment Videos
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Maintenance of PARP Inhibitor Rechallenge plus Bevacizumab in Patients with Platinum-Sensitive, Recurrent Ovarian Cancer Previously Treated with a PARP Inhibitor.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Predictive value of BRCA1/RAD51C methylation in HGSOC - An ancillary study of the PAOLA-1/ENGOT-ov25 phase 3 trial.
European journal of cancer (Oxford, England : 1990)·2025
Dostarlimab and niraparib in primary advanced ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
[Guidelines for the essential data entry in the European Bone Marrow Transplant Registry].
Bulletin du cancer·2026
[Transoral robotic surgery in head and neck cancers].
Bulletin du cancer·2026